Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

NCT04305756 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT04305756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04305756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
Lead sponsor
University of Utah
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2020
Completion date
December 15, 2021
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum dvt, thromboembolism, thrombosis